Philip Beer

8.7k citations

87 papers · 4.6k indexed · 2 hit papers · h-index 32

Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 24
- Chronic Lymphocytic Leukemia Research 6
Hematology top 0.2%
- Acute Myeloid Leukemia Research 18
- Chronic Myeloid Leukemia Treatments 18
- Hematopoietic Stem Cell Transplantation 12
Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 9
Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
Molecular Biology top 5%
- Kruppel-like factors research 16

Co-authors: Anthony R. Green Claire Harrison Wendy N. Erber Mary Frances McMullin Linda M. Scott Peter J. Campbell Connie J. Eaves Mike Scott
Cited by: Genetics Hematology Rheumatology
Journals: Blood (27 papers)British Journal of Haematology (6 papers)Haematologica (6 papers)
Partner nations: United Kingdom Canada United States

In The Last Decade

Philip Beer

85 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Philip Beer

Since Specialization

Citations

This map shows the geographic impact of Philip Beer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Beer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Beer more than expected).

Fields of papers citing papers by Philip Beer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Beer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Beer. The network helps show where Philip Beer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip Beer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Beer Line = papers co-authored together Philip Beer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma Haematologica ·Nguyen Thi Van,Céline Bellanger,SmithJonesTom,Benoît Tessoulin,Christelle Dousset,Emmanuelle Ménoret,Hélène Asnagli,Andrew Parker,Philip Beer,Catherine Pellat‐Deceunynck,David Chiron	2024	1
2	Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network Blood Advances ·Simon Crouch,Daniel Painter,Sharon Barrans,Eve Roman,Philip Beer,Susanna L. Cooke,Paul Glover,Ch. Jayasree,Nichola Webster,Stuart Lacy,Camilo Ruiz,Peter J. Campbell,Daniel J. Hodson,Russell Patmore,Cathy Burton,Alexandra Smith,Reuben Tooze	2022	17
3	Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors Clinical Cancer Research ·Apostolia M. Tsimberidou,Philip Beer,Carrie Cartwright,Cara Haymaker,Henry Hiep Vo,Simin Kiany,Alexander Cecil,FRANCIS J. GAVIN,Gor A. Gevorgian,正晟杉原,L.J. Reha-Krantz,Meylisa Dwi Cahyanti,Elisabeth A. Bone,Graciela M. Nogueras‐González,David Vining,嘉夫今野,Ignacio I. Wistuba	2021	46
4	MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus Blood ·Shruthi Srinivasan,Davide Pellacani,Naoto Nakamichi,Colin A. Hammond,Philip Beer,Alireza Lorzadeh,Michelle Moksa,Annaïck Carles,Misha Bilenky,Sylvain Lefort,Researcher Zaina SKIKRE,Brian T. Wilhelm,Andrew P. Weng,Martin Hirst,Connie J. Eaves	2020	18
5	Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportbreakdown → Blood ·Stuart Lacy,Sharon Barrans,Philip Beer,Daniel Painter,Alexandra Smith,Eve Roman,Susanna L. Cooke,Camilo Ruiz,Paul Glover,G.G. Anderson,Nichola Webster,Peter J. Campbell,Reuben Tooze,Russell Patmore,Cathy Burton,Simon Crouch,Daniel J. Hodson	2020	260
6	Genetic modification of primary human B cells to model high-grade lymphoma Nature Communications ·Rebecca Caeser,Miriam Di Re,Mei Ling Lo,Jie Gao,Maribel Lara‐Chica,João M.L. Dias,Susanna L. Cooke,郭熹娅,Felisa Cançado Anaya,B Moujemmi,Philip Beer,Hesham Eldaly,Carlos Puertas,Chan-Sik Park,George S. Vassiliou,Brian J.P. Huntly,Annalisa Mupo,Rachael Bashford-Rogers,Daniel J. Hodson	2019	36
7	Assays for functionally defined normal and malignant mammary stem cells Advances in cancer research ·C.D. Gullett,Philip Beer,Nagarajan Kannan	2019	2
8	The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma Clinical Cancer Research ·Susanna L. Cooke,Darren Ennis,Lisa Evers,Suzanne Dowson,雄介田中,James Paul,Lynn Hirschowitz,Rosalind Glasspool,Naveena Singh,Sarah Bell,Ali Abbassian,Agata Kochman,Nafisa Wilkinson,Philip Beer,Sancha Martin,David Millan,Andrew V. Biankin,Iain A. McNeish	2017	29
9	Molecular and biological analysis of human hematopoietic stem cells at single-cell resolution Experimental Hematology ·Connie J. Eaves,David J. H. F. Knapp,Colin A. Hammond,Hanfei Lin,Malhar Dave,Davide Pellacani,C. da Silva,Paul H. Miller,Alireza Lorzadeh,Nima Aghaeepour,Michelle Moksa,Michael VanInsberghe,Mingliang Ye,Philip Beer,R. Keith Humphries,Sean C. Bendall,Garry P. Nolan,Carl L. Hansen,Martin Hirst	2017	1
10	Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice Blood ·Alice M.S. Cheung,Long Nguyen,Annaïck Carles,Philip Beer,Paul H. Miller,David J. H. F. Knapp,Kiran Dhillon,Martin Hirst,Connie J. Eaves	2013	77
11	The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells Nature Cell Biology ·Michael R. Copley,Sonja Babovic,Claudia Benz,David J. H. F. Knapp,Philip Beer,David G. Kent,Stefan Wöhrer,Lineker Chen,Christopher Day,Keegan Rowe,晴美池田,Florian Kuchenbauer,R. Keith Humphries,Connie J. Eaves	2013	254
12	In situ thrombolysis for cerebral venous thrombosis complicating anti-leukemic therapy Leukemia Research ·Anna L. Godfrey,Nicholas Higgins,Philip Beer,Jenny I. O. Craig,George S. Vassiliou	2011	4
13	The pathogenesis of essential thrombocythemia Current Opinion in Hematology ·Philip Beer	2011	9
14	Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms Haematologica ·Philip Beer,Christina A. Ortmann,Frank Stegelmann,Paola Guglielmelli,John T. Reilly,Thomas Stauffer Larsen,Hans Carl Hasselbalch,Khalil Ahmed Veesar,Per Werner Möller,Konstanze Döhner,Anthony R. Green	2010	17
15	Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase Haematologica ·Philip Beer,Peter J. Campbell,Anthony R. Green	2010	14
16	AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders British Journal of Haematology ·Mark A. Dawson,Jayne Curry,E N Masland,Philip Beer,Brent Graham,John F. Lyons,Caroline J. Richardson,Mike Scott,Tomoko Smyth,Matthew Squires,Neil T. Thompson,Anthony R. Green,Nicola G. Wallis	2010	41
17	Erythropoietin synthesis is primarily regulated by the PHD2-HIF-2alpha-VHL axis as documented by HIF-2alpha associated familial erythrocytosis British Journal of Haematology ·Melanie J. Percy,Paul W. Furlow,Philip Beer,Gavin Campbell,A. W. Dekker,Anthony R. Green,胡正海,鐡男八重樫,David Oscier,Максим Анатольевич Козаченко,Зиятдинова Диана Дамировна,Michelle A. Wood,T. R. J. Lappin,Mary Frances McMullin,恩博赵,権藤公和	2009	0
18	Pathogenesis and management of essential thrombocythemia Hematology ·Philip Beer,Anthony R. Green	2009	23
19	A novel Arg371His mutation in the HIF prolyl hydroxylase PHD2 is associated with erythrocytosis Haematologica ·徹桜井,Paul W. Furlow,Philip Beer,Terence R.J. Lappin,Mary Frances McMullin,THH. Chen	2007	1
20	JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosisbreakdown → New England Journal of Medicine ·Linda M. Scott,Wei Tong,Ross L. Levine,Mike Scott,Philip Beer,Michael R. Stratton,P. Andrew Futreal,Wendy N. Erber,Mary Frances McMullin,Claire Harrison,Alan J. Warren,D. Gary Gilliland,Harvey F. Lodish,Anthony R. Green	2007	898

About Philip Beer

Philip Beer is a scholar working on Hematology, Genetics and Cancer Research, having authored 87 papers that have together received 4.6k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (18 papers), Kruppel-like factors research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers), Cancer Genomics and Diagnostics (11 papers), Eosinophilic Disorders and Syndromes (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Genetics (2.7k citations), Hematology (2.3k citations) and Rheumatology (955 citations). Philip Beer has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Anthony R. Green, Claire Harrison, Wendy N. Erber, Mary Frances McMullin, Linda M. Scott, Peter J. Campbell, Connie J. Eaves, Mike Scott, Wei Tong and P. Andrew Futreal. Their work appears in journals such as Blood, British Journal of Haematology, Haematologica, Experimental Hematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact